Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma, Ewing × Epirubicin × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Triple Negative Breast Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 2 Resectable HER2-positive Breast Cancer 1 Pathologic Complete Response 1 Non-Muscle Invasive Bladder Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, T-Cell, Peripheral 1 Inflammatory Breast Neoplasms 1 HR+/HER2- Breast Cancer 1 Epstein-Barr Virus Infections 1 Congenital Abnormalities 1 Carcinoma, Adenoid Cystic 1 CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction 1

Interventions

Temozolomide 12 Vincristine 8 Irinotecan 8 Cyclophosphamide 7 Etoposide 5 cabozantinib 4 X-Rays 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Ifosfamide 4 Doxorubicin 4 regorafenib 3 fludarabine 3 Radiotherapy 3 Radiation 3 Phantoms, Imaging 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 olaparib 2 liposomal doxorubicin 2 ivosidenib 2 irinotecan sucrosofate 2 etoposide phosphate 2 abemaciclib 2 Zoledronic Acid 2 Topotecan 2 Surgical Procedures, Operative 2 Sirolimus 2 Radiotherapy, Image-Guided 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡